Last Updated 00:00:00
longbridge loading
Company Encyclopedia
name
SHANGHAI KAIBAO
300039.SZ
Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and respiratory infections; and Phlegm-Heat Clearing Capsules to clear heat, resolve phlegm, and detoxifying. It also provides liver-protecting products, including Thiopronine for injection and Thiopronine enteric-coated tablets. In addition, the company provides Astragalus and Ginseng Capsules for the treatment of cardiovascular and cerebrovascular diseases.
2.562 T
300039.SZMarket value -Rank by Market Cap -/-

Financial Score

15/06/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking137/222
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE5.83%C
    • Profit Margin25.03%A
    • Gross Margin80.82%A
  • Growth ScoreD
    • Revenue YoY-25.97%E
    • Net Profit YoY-30.22%D
    • Total Assets YoY8.75%B
    • Net Assets YoY11.08%B
  • Cash ScoreD
    • Cash Flow Margin73.20%C
    • OCF YoY-25.97%E
  • Operating ScoreD
    • Turnover0.21D
  • Debt ScoreA
    • Gearing Ratio8.14%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --